CD55 / DAF Protein Price Inquiry ( Available Sizes )
CD55 / DAF Protein Product Information
||AC111067.1, Daf, Daf-GPI, Daf1, GPI-DAF
||A DNA sequence encoding the mature form of mouse CD55 (Q61475) (Met 1-Thr 361) was expressed, with a C-terminal polyhistidine tag.
CD55 / DAF Protein QC Testing
||> 92 % as determined by SDS-PAGE.
CD55 / DAF protein
||< 1.0 EU per μg of the protein as determined by the LAL method
||Samples are stable for up to twelve months from date of receipt at -70℃
|Predicted N terminal:
||The secreted recombinant mouse CD55 comprises 338 amino acids and has a calculated molecular mass of 37.2 kDa. As a result of glycosylation, the apparent molecular mass of rmCD55 is approximately 60 kDa in SDS-PAGE under reducing conditions.
||Lyophilized from sterile PBS , pH 7.4
- Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
- Please contact us for any concerns or special requirements.
CD55 / DAF Protein Usage Guide
||Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
||A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
CD55 / DAF Protein Related Products & Topics
CD55 / DAF Protein Description
CD55, also well known as decay-accelerating factor (DAF), is a member of the RCA (regulators of complement activation) family characterized by four to 30 SCRs (short consensus repeats) in their plasma-exposed regions. This 70-75 kDa glycoprotein CD55 containing four SCR modules is involved in the regulation of the complement cascade. It interferes with the functions of C3 and C5 convertases in both the classical and alternative pathways by preventing the assembly of the C3bBb complex or accelerating the disassembly of preformed convertase, and thus disrupts the cascade and protects the host cells from damage. Antigens present on the CD55/DAF constitute determinant for the Cromer blood group system. CD55/DAF has been identified as a ligand for an activation-associated, seven-transmembrane lymphocyte receptor, CD97, which is a receptor mediating attachment and infection of several viruses and bacteria. In addition, it has been shown that CD55/DAF regulates the interplay between complement and T cell immunity in vivo, and thus may be implicated in immune and tumor biology. There are two variants of CD55 encoded by alternatively spliced transcripts, the predominant variant is a GPI-anchored membrane form ubiquitously expressed on cells exposed to plasma complement proteins, whereas a soluble form present at much lower level.
- Bergelson JM. et al., 1994, Proc Natl Acad Sci. 91: 6245-8.
- Terstappen LW. et al., 1992, J Leuro Biol. 52: 652-60.
- Liu J. et al., 2005, J Exp Med. 201: 567-77.
- Madjd Z. et al., 2004, Clin Cancer Res. 10: 2797-803.
- Mikesch JH. et al., 2007, Cell Oncol. 28: 223-32.
CD55 / DAF related areas, pathways, and other information